Ulcus cruris venosum (UCV) is the most severe form of chronic venous insufficiency and the quality of life of those affected is usually significantly impaired. In the updated s2k guideline published in 2024, the focus was on the prevention of UCV recurrences in addition to the quality of examination and treatment procedures. It is a practice-oriented guideline that combines the different approaches and levels of knowledge of the respective professional groups and offers a practicable treatment concept for UCV.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- From Risk Identification to Anti-Inflammatory Intervention
Inflammation as a Treatment Goal in Its Own Right
- Psoriasis Research: What's in the Pipeline?
Highly selective oral TYK inhibitors in Phase III
- Cardiometabolism
Retatrutid and the TRIUMPH Program: The Triple Agonist on the Horizon
- Pediatric Retinoblastoma
The Tumor Microenvironment and Modern Eye-Sparing Therapies
- Adherence and management in asthma and COPD
Better to listen to the pharmacist
- Focus Update 2026
Echocardiography in Cardio-Oncology
- Physical activity with IBD
Sport is not murder, but it doesn’t help either
- White and Black Skin Cancer